Correction to: Rebuttal letter on “Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature” (Clinical Rheumatology, (2021), 40, 5, (2107-2108), 10.1007/s10067-021-05705-8)

Francisco Airton Castro Rocha; Atul Deodhar

doi:10.1007/s10067-021-05741-4

Correction to: Rebuttal letter on “Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature” (Clinical Rheumatology, (2021), 40, 5, (2107-2108), 10.1007/s10067-021-05705-8)

Francisco Airton Castro Rocha, Atul Deodhar

Arthritis and Rheumatic Diseases

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

A correction to this paper has been published: https://doi.org/10.1007/s10067-021-05741-4.

Original language	English (US)
Pages (from-to)	3025
Number of pages	1
Journal	Clinical Rheumatology
Volume	40
Issue number	7
DOIs	https://doi.org/10.1007/s10067-021-05741-4
State	Published - Jul 2021

ASJC Scopus subject areas

Rheumatology

Access to Document

10.1007/s10067-021-05741-4

Fingerprint

Dive into the research topics of 'Correction to: Rebuttal letter on “Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature” (Clinical Rheumatology, (2021), 40, 5, (2107-2108), 10.1007/s10067-021-05705-8)'. Together they form a unique fingerprint.

Cite this

Rocha, F. A. C., & Deodhar, A. (2021). Correction to: Rebuttal letter on “Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature” (Clinical Rheumatology, (2021), 40, 5, (2107-2108), 10.1007/s10067-021-05705-8). Clinical Rheumatology, 40(7), 3025. https://doi.org/10.1007/s10067-021-05741-4

Correction to: Rebuttal letter on “Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature” (Clinical Rheumatology, (2021), 40, 5, (2107-2108), 10.1007/s10067-021-05705-8). / Rocha, Francisco Airton Castro; Deodhar, Atul.
In: Clinical Rheumatology, Vol. 40, No. 7, 07.2021, p. 3025.

Research output: Contribution to journal › Comment/debate › peer-review

Rocha, FAC & Deodhar, A 2021, 'Correction to: Rebuttal letter on “Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature” (Clinical Rheumatology, (2021), 40, 5, (2107-2108), 10.1007/s10067-021-05705-8)', Clinical Rheumatology, vol. 40, no. 7, pp. 3025. https://doi.org/10.1007/s10067-021-05741-4

Rocha FAC, Deodhar A. Correction to: Rebuttal letter on “Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature” (Clinical Rheumatology, (2021), 40, 5, (2107-2108), 10.1007/s10067-021-05705-8). Clinical Rheumatology. 2021 Jul;40(7):3025. doi: 10.1007/s10067-021-05741-4

Rocha, Francisco Airton Castro ; Deodhar, Atul. / Correction to : Rebuttal letter on “Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature” (Clinical Rheumatology, (2021), 40, 5, (2107-2108), 10.1007/s10067-021-05705-8). In: Clinical Rheumatology. 2021 ; Vol. 40, No. 7. pp. 3025.

@article{c82a6e7aba7748b1b9a816b54573faec,

title = "Correction to: Rebuttal letter on “Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature” (Clinical Rheumatology, (2021), 40, 5, (2107-2108), 10.1007/s10067-021-05705-8)",

abstract = "A correction to this paper has been published: https://doi.org/10.1007/s10067-021-05741-4.",

author = "Rocha, {Francisco Airton Castro} and Atul Deodhar",

note = "Publisher Copyright: {\textcopyright} 2021, International League of Associations for Rheumatology (ILAR).",

year = "2021",

month = jul,

doi = "10.1007/s10067-021-05741-4",

language = "English (US)",

volume = "40",

pages = "3025",

journal = "Clinical Rheumatology",

issn = "0770-3198",

publisher = "Springer London",

number = "7",

}

TY - JOUR

T1 - Correction to

T2 - Rebuttal letter on “Comment on tumor necrosis factor inhibitors prevent structural damage in hips in ankylosing spondylitis—time to reconsider treatment guidelines? A case series and review of literature” (Clinical Rheumatology, (2021), 40, 5, (2107-2108), 10.1007/s10067-021-05705-8)

AU - Rocha, Francisco Airton Castro

AU - Deodhar, Atul

PY - 2021/7

Y1 - 2021/7

N2 - A correction to this paper has been published: https://doi.org/10.1007/s10067-021-05741-4.

AB - A correction to this paper has been published: https://doi.org/10.1007/s10067-021-05741-4.

UR - http://www.scopus.com/inward/record.url?scp=85105524587&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85105524587&partnerID=8YFLogxK

U2 - 10.1007/s10067-021-05741-4

DO - 10.1007/s10067-021-05741-4

M3 - Comment/debate

C2 - 33948769

AN - SCOPUS:85105524587

SN - 0770-3198

VL - 40

SP - 3025

JO - Clinical Rheumatology

JF - Clinical Rheumatology

IS - 7

ER -

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this